显示筛选器
哦! 抱歉，出了点问题。点击其他产品继续购物Help End Breast Cancer | Breakthrough Research
广告More than 1,200 potential breast cancer treatments are in the research pipeline. Komen has invested $25 million this past year in lifesaving research to end breast cancer.Inspiring Change · Get Involved · Latest News & Events · Give to Research
Service catalog: Educational Materials, Facts & Statistics, Screening & DetectionLimited-Stage SCLC | LS-SCLC cCRT Progression Info
广告LS-SCLC Patients Are At High Risk Of Progression Following cCRT Completion. LS-SCLC Physicians: Learn More About The High-Risk Progression Period Following cCRT.cCRT Treatment Info · Limited-Stage SCLC Info · LS-SCLC cCRT Progression
Service catalog: LS-SCLC Progression, Review The HCP Data, LS-SCLC MDT Study Data
反馈